{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:37:43Z","timestamp":1786117063908,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.abb.2026.110951","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:38:17Z","timestamp":1785307097000},"page":"110951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CLOCK confers EGFR-TKIs resistance in non-small cell lung cancer by transcriptionally upregulating LAMC2 expression and activating multiple kinase signaling"],"prefix":"10.1016","volume":"784","author":[{"given":"Yankang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houbao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2026.110951_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.abb.2026.110951_bib2","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1158\/0008-5472.CAN-09-3421","article-title":"Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations","volume":"70","author":"Lazzara","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110951_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrm3048","article-title":"Feedback regulation of EGFR signalling: decision making by early and delayed loops","volume":"12","author":"Avraham","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.abb.2026.110951_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"Tomas","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.abb.2026.110951_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11523-013-0258-9","article-title":"Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)","volume":"8","author":"Kobayashi","year":"2013","journal-title":"Targeted Oncol."},{"key":"10.1016\/j.abb.2026.110951_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101266","article-title":"Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer","volume":"82","author":"Du","year":"2025","journal-title":"Drug Resist. Updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.abb.2026.110951_bib7","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol. : official journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.abb.2026.110951_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/rccm.201602-0300OC","article-title":"Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors","volume":"195","author":"Chang","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.abb.2026.110951_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-021-00847-2","article-title":"LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.abb.2026.110951_bib10","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1158\/0008-5472.CAN-06-1349","article-title":"The neuromedin U-growth hormone secretagogue receptor 1b\/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer","volume":"66","author":"Takahashi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2026.110951_bib11","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-10-0659","article-title":"Neurotensin receptor 1 determines the outcome of non-small cell lung cancer","volume":"16","author":"Alifano","year":"2010","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.abb.2026.110951_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12964-024-01747-y","article-title":"Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress","volume":"22","author":"Lu","year":"2024","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.abb.2026.110951_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13543776.2024.2446220","article-title":"A patent review of small molecular inhibitors targeting EGFR exon 20 insertion (Ex20ins) (2019-present)","volume":"35","author":"Zhu","year":"2025","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.abb.2026.110951_bib14","doi-asserted-by":"crossref","first-page":"13605","DOI":"10.1021\/acsami.4c21740","article-title":"CRISPR-dCas9-Mediated PTEN activation via tumor cell membrane-coated nanoplatform enhances sensitivity to tyrosine kinase inhibitors in nonsmall cell lung cancer","volume":"17","author":"Yang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.abb.2026.110951_bib15","article-title":"Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics","author":"Chen","year":"2026","journal-title":"Sci. Bull."},{"key":"10.1016\/j.abb.2026.110951_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jtho.2024.11.027","article-title":"Receptor tyrosine kinase fusion-mediated resistance to EGFR TKI in EGFR-Mutant NSCLC: a multi-center analysis and literature review","volume":"20","author":"Xia","year":"2025","journal-title":"J. Thorac. Oncol. : official publication of the International Association for the Study of Lung Cancer"},{"key":"10.1016\/j.abb.2026.110951_bib17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.aao6891","article-title":"Rev-erb\u03b1 dynamically modulates chromatin looping to control circadian gene transcription","volume":"359","author":"Kim","year":"2018","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.abb.2026.110951_bib18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1101\/gad.352841.125","article-title":"H3K4me3 amplifies transcription at intergenic active regulatory elements","volume":"39","author":"Yu","year":"2025","journal-title":"Gene Dev."},{"key":"10.1016\/j.abb.2026.110951_bib19","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202501221","article-title":"RTF1 enhances CLK occupancy and histone methylation at key circadian clock pacemaker gene loci","volume":"224","author":"Liu","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.abb.2026.110951_bib20","article-title":"Oncogenic roles of laminin subunit Gamma-2 in intrahepatic cholangiocarcinoma via promoting EGFR translation","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Scie. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.abb.2026.110951_bib21","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.3748\/wjg.v28.i35.5154","article-title":"Alcohol promotes epithelial mesenchymal transformation-mediated premetastatic niche formation of colorectal cancer by activating interaction between laminin-\u03b32 and integrin-\u03b21","volume":"28","author":"Nong","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.abb.2026.110951_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00018-022-04392-1","article-title":"Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR\/ERK1\/2\/AKT\/mTOR cascade","volume":"79","author":"Kirtonia","year":"2022","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.abb.2026.110951_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12592","article-title":"Rab25 promotes erlotinib resistance by activating the \u03b21 integrin\/AKT\/\u03b2-catenin pathway in NSCLC","volume":"52","author":"Wang","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.abb.2026.110951_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41388-023-02645-2","article-title":"Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3\u03b2 Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer","volume":"42","author":"Huang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.abb.2026.110951_bib25","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1158\/1535-7163.MCT-19-0181","article-title":"Acquired resistance to EGFR TKIs mediated by TGF\u03b21\/Integrin \u03b23 signaling in EGFR-Mutant lung cancer","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.abb.2026.110951_bib26","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214829120","article-title":"Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle","volume":"120","author":"Qu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.abb.2026.110951_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-019-1880-9","article-title":"Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies","volume":"17","author":"Chang","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.abb.2026.110951_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12967-021-03068-x","article-title":"Circadian rhythms affect bone reconstruction by regulating bone energy metabolism","volume":"19","author":"Luo","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.abb.2026.110951_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1186\/s12967-024-05475-2","article-title":"Circadian rhythm disruption upregulating Per1 in mandibular condylar chondrocytes mediating temporomandibular joint osteoarthritis via GSK3\u03b2\/\u03b2-CATENIN pathway","volume":"22","author":"Wei","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.abb.2026.110951_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/EBC20180075","article-title":"Structural biology of laminins","volume":"63","author":"Hohenester","year":"2019","journal-title":"Essays Biochem."},{"key":"10.1016\/j.abb.2026.110951_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063682","article-title":"LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis","volume":"12","author":"Fu","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.abb.2026.110951_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7248064","article-title":"Overexpression of laminin 5\u03b32 chain correlates with tumor cell proliferation, invasion, and poor prognosis in laryngeal squamous cell carcinoma","volume":"2022","author":"Yin","year":"2022","journal-title":"J. Oncology."},{"key":"10.1016\/j.abb.2026.110951_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00432-024-05720-7","article-title":"LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K\/Akt signaling pathway","volume":"150","author":"Cheng","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.abb.2026.110951_bib34","article-title":"20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters","author":"Wu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.abb.2026.110951_bib35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41417-023-00654-7","article-title":"LAMC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer","volume":"30","author":"Tong","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.abb.2026.110951_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-016-0290-1","article-title":"EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer","volume":"9","author":"Wang","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.abb.2026.110951_bib37","doi-asserted-by":"crossref","first-page":"re6","DOI":"10.1126\/scisignal.2004652","article-title":"Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer","volume":"6","author":"Niederst","year":"2013","journal-title":"Sci. Signal."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:03:50Z","timestamp":1786021430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0003986126002237"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110951","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CLOCK confers EGFR-TKIs resistance in non-small cell lung cancer by transcriptionally upregulating LAMC2 expression and activating multiple kinase signaling","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110951"}}